Search

Mehmet T Dorak

from Pembroke Pines, FL
Age ~65
Get Report
Also known as:
Melmet T Dorak, Mark Dorak
Related to:
Christina S Dorak, 72
Connected to:
Michelle A Dorak, 38Yvon Doralus, 61Elizabeth M Dorame, 37Reyes Dorame, 38Selina R Dorame, 58Amanda Doran, 43Amy Doran, 57Barry R Doran, 75Blake T Doran, 41Caitlyn A Doran, 36

Mehmet Dorak Phones & Addresses

  • Pembroke Pines, FL
  • Trenton, NJ
  • Milltown, NJ
  • Homewood, AL
  • Miami, FL

Publications

Us Patents

Single Nucleotide Polymorphisms And Use Of Same Predicting Male- Specific Prenatal Loss

View page
US Patent:
20100081135, Apr 1, 2010
Filed:
Apr 14, 2009
Appl. No.:
12/386106
Inventors:
Mehmet Tevfik Dorak - Hamilton NJ, US
Charronne Davis - Mahwah NJ, US
Thuy Ngoc Do - Hamilton NJ, US
Assignee:
Medical Diagnostic Laboratories, LLC - Hamilton NJ
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific prenatal loss of a conceptus or embryo. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk of prenatal loss is also disclosed.

Single Nucleotide Polymorphisms As Genetic Markers For Childhood Leukemia

View page
US Patent:
20100092959, Apr 15, 2010
Filed:
Jun 3, 2009
Appl. No.:
12/455520
Inventors:
Mehmet Tevfik Dorak - Hamilton NJ, US
Thuy Ngoc Do - Hamilton NJ, US
Charronne Davis - Mahwah NJ, US
Brittany Morrison - Hamilton NJ, US
Assignee:
Medical Diagnostic Laboratories, LLC - Hamilton NJ
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific childhood leukemia risk. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk or a decreased risk for childhood leukemia for males and females is also disclosed.

Novel Haplotype Tagging Single Nucleotide Polymorphisms And Use Of Same To Predict Childhood Lymphoblastic Leukemia

View page
US Patent:
20110086346, Apr 14, 2011
Filed:
Feb 9, 2010
Appl. No.:
12/658269
Inventors:
Charronne Florence Davis - Elkins Park PA, US
Mehmet Tevfik Dorak - Pembroke Pines FL, US
Assignee:
Medical Diagnostic Laboratories LLC - Hamilton NJ
International Classification:
C12Q 1/68
G01N 33/00
US Classification:
435 6, 436 94
Abstract:
The present invention is directed to novel haplotype tagging single nucleotide polymorphisms (SNPs) in specific regions outside the HFE gene that serve as a reliable biomarker for a decreased risk for childhood lymphoblastic leukemia (ALL) in a child. There is provided herein methods and reagents for assessing the haplotype tagging SNPs selected from the group consisting of rs807212, rs198853, rs9467664, rs2213284, rs2230655 and rs12346. The method useful in applying these SNPs in predicting a decreased risk of childhood lymphoblastic leukemia (ALL) is also disclosed.

Single Nucleotide Polymorphisms And Use Of Same In Predicting Male-Specific Prenatal Loss

View page
US Patent:
20140045710, Feb 13, 2014
Filed:
Feb 12, 2013
Appl. No.:
13/764803
Inventors:
Mehmet Tevik Dorak - Hamilton NJ, US
Charronne Davis - Mahwah NJ, US
Thuy Ngoc Do - Hamilton NJ, US
Assignee:
Medical Diagnostic Laboratories, LLC - Hamilton NJ
International Classification:
C12Q 1/68
US Classification:
506 9, 435 611
Abstract:
The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific prenatal loss of a conceptus or embryo. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk of prenatal loss is also disclosed.

Novel Haplotype Tagging Single Nucleotide Polymorphisms And Use Of Same To Predict Childhood Lymphoblastic Leukemia

View page
US Patent:
20160053333, Feb 25, 2016
Filed:
Nov 11, 2015
Appl. No.:
14/938241
Inventors:
Charronne Florence Davis - Ramapo NJ, US
Mehmet Tevfik Dorak - Pembroke Pines FL, US
Assignee:
MEDICAL DIAGNOSTIC LABORATORIES, LLC - Hamilton NJ
International Classification:
C12Q 1/68
Abstract:
The present invention is directed to novel haplotype tagging single nucleotide polymorphisms (SNPs) in specific regions outside the HFE gene that serve as a reliable biomarker for a decreased risk for childhood lymphoblastic leukemia (ALL) in a child. There is provided herein methods and reagents for assessing the haplotype tagging SNPs selected from the group consisting of rs807212, rs198853, rs9467664, rs2213284, rs2230655 and rs12346. The method useful in applying these SNPs in predicting a decreased risk of childhood lymphobastic leukemia (ALL) is also disclosed.
Control profile
Mehmet T Dorak from Pembroke Pines, FL, age ~65 Get Report